NCT04250506View on ClinicalTrials.gov

A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

July 22, 2020

Study Completion Date

July 22, 2020

Conditions
Healthy
Interventions
DRUG

Daridorexant

Daridorexant (ACT-541468) administered as film-coated tablets for oral use.

DRUG

Placebo

Placebo administered as tablets for oral use.

DRUG

Moxifloxacin

Moxifloxacin administered as film-coated tablets for oral use.

Trial Locations (1)

323 00

CEPHA s.r.o., Pilsen

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY